Anterix Inc Financials
This page shows Anterix Inc (ATEX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 14 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Anterix’s business mechanic is a large asset base carrying heavy overhead while current revenue and capex remain small.
The clearest signal is cash conversion quality: FY2024 operating cash flow was$41.9M against a net loss of-$9.1M , but FY2025 operating cash flow fell to-$29.3M while the net loss changed only to-$11.4M . With capex just$87K in FY2025, free cash flow moved almost one-for-one with operating cash flow, showing that cash availability is being driven far more by the timing of inflows than by ongoing reinvestment demands.
The balance sheet still provides near-term liquidity: cash of
The bigger operating issue is scale mismatch: FY2025 revenue of
Financial Health Signals
Scored against emerging companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Anterix Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Anterix Inc scores 5.78, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($2.0B) relative to total liabilities ($202.9M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Anterix Inc passes 5 of 7 computable financial strength tests (2 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, Anterix Inc generates $60.80 in operating cash flow ($5.5M OCF vs $91K net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Key Financial Metrics
Earnings & Revenue
Anterix Inc generated $6.5M in revenue in fiscal year 2026. This represents an increase of 7.8% from the prior year.
Anterix Inc's EBITDA was $94.4M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 945.4% from the prior year.
Anterix Inc reported $91K in net income in fiscal year 2026. This represents an increase of 897.0% from the prior year.
Anterix Inc earned $4.83 per diluted share (EPS) in fiscal year 2026. This represents an increase of 891.8% from the prior year.
Cash & Balance Sheet
Anterix Inc generated $5.5M in free cash flow in fiscal year 2026, representing cash available after capex. This represents an increase of 118.7% from the prior year.
Anterix Inc held $98.5M in cash against $0 in long-term debt as of fiscal year 2026.
Anterix Inc had 19M shares outstanding in fiscal year 2026. This represents an increase of 1.6% from the prior year.
Margins & Returns
Anterix Inc's gross margin was 99.1% in fiscal year 2026, indicating the percentage of revenue retained after direct costs.
Anterix Inc's operating margin was 1444.8% in fiscal year 2026, reflecting core business profitability. This is up 1639.1 percentage points from the prior year.
Anterix Inc's net profit margin was 1.4% in fiscal year 2026, showing the share of revenue converted to profit. This is up 1.6 percentage points from the prior year.
Anterix Inc's ROE was 0.0% in fiscal year 2026, measuring profit generated per dollar of shareholder equity. This is up 0.0 percentage points from the prior year.
Capital Allocation
Anterix Inc invested $4.7M in research and development in fiscal year 2026. This represents a decrease of 18.0% from the prior year.
Anterix Inc spent $990K on share buybacks in fiscal year 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 88.2% from the prior year.
Anterix Inc invested $31K in capex in fiscal year 2026, funding long-term assets and infrastructure. This represents a decrease of 64.4% from the prior year.
ATEX Income Statement
| Metric | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.0M+24.5% | $1.6M+1.4% | $1.6M+9.4% | $1.4M+2.1% | $1.4M-11.3% | $1.6M+1.0% | $1.6M+1.7% | $1.5M |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | $1.3M+14.8% | $1.1M-8.9% | $1.2M+8.2% | $1.1M+2.8% | $1.1M-2.8% | $1.1M-36.9% | $1.8M+1.5% | $1.8M |
| SG&A Expenses | $8.6M-1.1% | $8.7M+3.1% | $8.4M-19.6% | $10.4M+13.3% | $9.2M+0.2% | $9.2M-19.3% | $11.4M-11.3% | $12.9M |
| Operating Income | $19.8M+318.9% | -$9.1M-114.9% | $60.7M+169.9% | $22.5M+139.3% | $9.4M+33.6% | $7.0M+153.6% | -$13.1M+12.5% | -$15.0M |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax | $1.9M+190.7% | -$2.1M-127.3% | $7.5M+433.1% | -$2.3M-434.9% | $674K+388.0% | -$234K-201.7% | $230K-81.2% | $1.2M |
| Net Income | -$72.0M-991.1% | -$6.6M-112.3% | $53.5M+112.6% | $25.2M+22.4% | $20.6M+166.8% | $7.7M+160.4% | -$12.8M+17.8% | -$15.5M |
| EPS (Diluted) | N/A | $-0.35-112.2% | $2.86+111.9% | $1.35 | N/A | $0.41+159.4% | $-0.69+17.9% | $-0.84 |
ATEX Balance Sheet
| Metric | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $465.2M+11.6% | $417.0M-0.8% | $420.4M+16.9% | $359.6M+7.9% | $333.1M+2.0% | $326.7M+3.0% | $317.2M-1.2% | $321.1M |
| Current Assets | $120.0M+139.7% | $50.1M-14.9% | $58.8M+6.2% | $55.4M-8.9% | $60.8M+50.8% | $40.3M-29.1% | $56.8M-13.6% | $65.7M |
| Cash & Equivalents | $98.5M+233.6% | $29.5M-24.4% | $39.1M-5.7% | $41.4M-12.5% | $47.4M+64.5% | $28.8M-33.2% | $43.1M-16.6% | $51.7M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $202.9M+12.1% | $181.1M+0.6% | $180.0M+3.0% | $174.8M-1.0% | $176.5M-3.0% | $181.9M+2.1% | $178.2M+3.4% | $172.4M |
| Current Liabilities | $36.0M-0.1% | $36.0M+4.0% | $34.6M-3.7% | $35.9M+32.2% | $27.2M+11.5% | $24.4M+54.4% | $15.8M-4.3% | $16.5M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $262.3M+11.2% | $236.0M-1.8% | $240.3M+30.1% | $184.8M+18.0% | $156.6M+8.2% | $144.7M+4.1% | $139.1M-6.5% | $148.8M |
| Retained Earnings | -$302.3M+5.8% | -$320.8M-2.1% | -$314.2M+14.3% | -$366.8M+6.4% | -$391.9M+1.8% | -$399.2M+0.8% | -$402.5M-3.3% | -$389.7M |
ATEX Cash Flow Statement
| Metric | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $15.5M+287.6% | -$8.3M-689.2% | $1.4M+144.7% | -$3.1M+81.0% | -$16.6M-115.0% | -$7.7M-190.7% | -$2.6M-12.2% | -$2.4M |
| Capital Expenditures | $22K+144.4% | $9K | N/A | N/A | $46K | $0-100.0% | $41K | $0 |
| Free Cash Flow | $15.5M+287.1% | -$8.3M | N/A | N/A | -$16.6M-115.6% | -$7.7M-186.3% | -$2.7M-13.9% | -$2.4M |
| Investing Cash Flow | $46.1M+2103.7% | -$2.3M-281.0% | -$604K+77.3% | -$2.7M-107.5% | $35.4M+2162.6% | -$1.7M+69.0% | -$5.5M-2.7% | -$5.4M |
| Financing Cash Flow | $5.2M+51630.0% | -$10K+98.9% | -$907K-41.3% | -$642K-143.2% | -$264K+94.6% | -$4.9M-1251.7% | -$362K+66.2% | -$1.1M |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | $0 | $0-100.0% | $990K | $0-100.0% | $2.0M-55.7% | $4.4M | $0-100.0% | $2.0M |
ATEX Financial Ratios
| Metric | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | 1013.0%+1589.0pp | -576.0%-4485.5pp | 3909.5%+2324.1pp | 1585.4%+908.9pp | 676.5%+227.4pp | 449.0%+1295.6pp | -846.6%+137.8pp | -984.4% |
| Net Margin | -3678.5%-3258.8pp | -419.6%-3869.1pp | 3449.5%+1673.7pp | 1775.7%+294.9pp | 1480.8%+988.5pp | 492.3%+1315.4pp | -823.1%+194.9pp | -1018.0% |
| Return on Equity | -27.5%-24.7pp | -2.8%-25.1pp | 22.3%+8.6pp | 13.6%+0.5pp | 13.1%+7.8pp | 5.3%+14.5pp | -9.2%+1.2pp | -10.4% |
| Return on Assets | -15.5%-13.9pp | -1.6%-14.3pp | 12.7%+5.7pp | 7.0%+0.8pp | 6.2%+3.8pp | 2.4%+6.4pp | -4.0%+0.8pp | -4.8% |
| Current Ratio | 3.33+1.9 | 1.39-0.3 | 1.70+0.2 | 1.54-0.7 | 2.23+0.6 | 1.65-1.9 | 3.59-0.4 | 3.98 |
| Debt-to-Equity | 0.770.0 | 0.77+0.0 | 0.75-0.2 | 0.95-0.2 | 1.13-0.1 | 1.26-0.0 | 1.28+0.1 | 1.16 |
| FCF Margin | 791.5%+1317.9pp | -526.5% | N/A | N/A | -1195.2%-703.6pp | -491.6%-318.3pp | -173.4%-18.6pp | -154.8% |
Similar Companies
Frequently Asked Questions
What is Anterix Inc's annual revenue?
Anterix Inc (ATEX) reported $6.5M in total revenue for fiscal year 2026. This represents a 7.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Anterix Inc's revenue growing?
Anterix Inc (ATEX) revenue grew by 7.8% year-over-year, from $6.0M to $6.5M in fiscal year 2026.
Is Anterix Inc profitable?
Yes, Anterix Inc (ATEX) reported a net income of $91K in fiscal year 2026, with a net profit margin of 1.4%.
What is Anterix Inc's EBITDA?
Anterix Inc (ATEX) had EBITDA of $94.4M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.
What is Anterix Inc's gross margin?
Anterix Inc (ATEX) had a gross margin of 99.1% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.
What is Anterix Inc's operating margin?
Anterix Inc (ATEX) had an operating margin of 1444.8% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.
What is Anterix Inc's net profit margin?
Anterix Inc (ATEX) had a net profit margin of 1.4% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.
What is Anterix Inc's return on equity (ROE)?
Anterix Inc (ATEX) has a return on equity of 0.0% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.
What is Anterix Inc's free cash flow?
Anterix Inc (ATEX) generated $5.5M in free cash flow during fiscal year 2026. This represents a 118.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Anterix Inc's operating cash flow?
Anterix Inc (ATEX) generated $5.5M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.
What are Anterix Inc's total assets?
Anterix Inc (ATEX) had $465.2M in total assets as of fiscal year 2026, including both current and long-term assets.
What are Anterix Inc's capital expenditures?
Anterix Inc (ATEX) invested $31K in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.
How much does Anterix Inc spend on research and development?
Anterix Inc (ATEX) invested $4.7M in research and development during fiscal year 2026.
What is Anterix Inc's current ratio?
Anterix Inc (ATEX) had a current ratio of 3.33 as of fiscal year 2026, which is generally considered healthy.
What is Anterix Inc's debt-to-equity ratio?
Anterix Inc (ATEX) had a debt-to-equity ratio of 0.77 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Anterix Inc's return on assets (ROA)?
Anterix Inc (ATEX) had a return on assets of 0.0% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.
What is Anterix Inc's Altman Z-Score?
Anterix Inc (ATEX) has an Altman Z-Score of 5.78, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Anterix Inc's Piotroski F-Score?
Anterix Inc (ATEX) has a Piotroski F-Score of 5 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Anterix Inc's earnings high quality?
Anterix Inc (ATEX) has an earnings quality ratio of 60.80x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Anterix Inc?
Anterix Inc (ATEX) scores 47 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.